Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 50, Issue 11

Issues

Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers

Christos K. Kontos / Andreas Scorilas
Published Online: 2012-07-12 | DOI: https://doi.org/10.1515/cclm-2012-0247

Abstract

Early diagnosis of cancer and early detection of relapse following surgery are critical for the effective treatment of the disease and for a positive clinical outcome. Identification of novel diagnostic, prognostic and predictive biomarkers will contribute utmost to clinical decision-making. The human tissue kallikrein and kallikrein-related peptidases (KLKs), encoded by the largest contiguous cluster of protease genes in the human genome, are secreted serine proteases with diverse expression patterns and physiological roles. The aberrant expression of KLKs in various malignancies as well as their involvement in many cancer-related processes, such as cell growth regulation, angiogenesis, invasion, and metastasis, has prompted scientists to investigate their potential as cancer biomarkers. Expression of distinct KLKs is associated with clinicopathological parameters of cancer patients. Moreover, several KLKs possess significant favorable or unfavorable prognostic value in various malignancies, with prostate-specific antigen (PSA) being the most widely used biomarker in clinical practice, today. KLKs are also considered as very promising biomarkers for cancer personalized medicine, especially for prediction and monitoring of patients’ response to chemotherapy, therefore opening up new horizons towards effective patient monitoring post-treatment. This review describes the current status of KLKs as tumor biomarkers.

Keywords: cancer prognosis; personalized medicine; tumor biomarkers

About the article

Christos K. Kontos

Dr. Christos K. Kontos is a Postdoctoral Fellow at the Department of Biochemistry and Molecular Biology, University of Athens. His research interests include the discovery and study of novel cancer biomarkers in the prognosis of colorectal cancer, head and neck squamous cell carcinoma, and hematological malignancies, as well as the cloning of alternatively spliced variants of cancer-related genes. So far, he has participated in several demanding research grants and received two annual fellowships for scientific excellence by the National Hellenic Research Foundation. He has published eight original research papers in international peer-reviewed scientific journals and four mini-reviews in the Atlas of Genetics and Cytogenetics in Oncology and Haematology. Recently, he has also deposited 10 original sequences in Genbank.

Andreas Scorilas

Dr. Andreas Scorilas holds the position of Associate Professor of Clinical Biochemistry in the Department of Biochemistry and Molecular Biology, University of Athens. His research team’s interests include the discovery and study of novel cancer biomarkers in the diagnosis, prognosis and treatment monitoring of human malignancies, as well as the development of highly sensitive methodologies in Molecular Diagnostics. He was a major investigator in the discovery and cloning of several cancer-related genes, including the novel apoptotic gene BCL2L12, the novel carcinoembryonic antigen gene CEAL1 as well as three novel members of the Kallikrein gene family. Dr. Scorilas has been honored with several international scientific awards and coordinated numerous demanding research grants. So far, he has more than 190 publications in high impact international scientific journals, accompanied by >4200 citations (h index=36).


Corresponding author: Andreas Scorilas, Department of Biochemistry and Molecular Biology, University of Athens, Panepistimiopolis, Athens 15701, Greece Phone: +30 2107274306, Fax: +30 2107274158


Received: 2012-04-17

Accepted: 2012-06-20

Published Online: 2012-07-12

Published in Print: 2012-11-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 50, Issue 11, Pages 1877–1891, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2012-0247.

Export Citation

©2012 by Walter de Gruyter Berlin Boston.Get Permission

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Amiram Sananes, Itay Cohen, Anat Shahar, Alexandra Hockla, Elena De Vita, Aubry K. Miller, Evette S. Radisky, and Niv Papo
Journal of Biological Chemistry, 2018, Volume 293, Number 33, Page 12663
[2]
[5]
Kyoko Nohara, Kazuhiko Yamada, Leo Yamada, Teruki Hagiwara, Toru Igari, Chizu Yokoi, Daisuke Soma, Satoshi Yamashita, Taeko Dohi, and Yuki I. Kawamura
General Thoracic and Cardiovascular Surgery, 2018
[6]
Panagiotis G. Adamopoulos, Christos K. Kontos, and Andreas Scorilas
Scientific Reports, 2017, Volume 7, Number 1
[7]
Tiphaine Delaunay, Lydia Deschamps, Meriem Haddada, Francine Walker, Antoninus Soosaipillai, Feryel Soualmia, Chahrazade El Amri, Eleftherios P. Diamandis, Maria Brattsand, Viktor Magdolen, and Dalila Darmoul
Molecular Oncology, 2017
[8]
Wolfgang Skala, Daniel T. Utzschneider, Viktor Magdolen, Mekdes Debela, Shihui Guo, Charles S. Craik, Hans Brandstetter, and Peter Goettig
Journal of Biological Chemistry, 2014, Volume 289, Number 49, Page 34267
[9]
Karolina Plaza, Magdalena Kalinska, Oliwia Bochenska, Ulf Meyer-Hoffert, Zhihong Wu, Jan Fischer, Katherine Falkowski, Laura Sasiadek, Ewa Bielecka, Barbara Potempa, Andrzej Kozik, Jan Potempa, and Tomasz Kantyka
Journal of Biological Chemistry, 2016, Volume 291, Number 36, Page 18753
[10]
Wai Han Yiu, Dickson W. L. Wong, Loretta Y. Y. Chan, Joseph C. K. Leung, Kwok Wah Chan, Hui Yao Lan, Kar Neng Lai, Sydney C. W. Tang, and Eric Jan
PLoS ONE, 2014, Volume 9, Number 2, Page e88894
[11]
Margaritis Avgeris and Andreas Scorilas
Expert Opinion on Therapeutic Targets, 2016, Volume 20, Number 7, Page 801
[12]
Lu Tan, Tatiana Meier, Mareike Kuhlmann, Feng Xie, Claas Baier, Zhen Zhu, Wen-ming Cong, and Ludwig Wilkens
Cancer Genetics, 2016, Volume 209, Number 3, Page 87
[13]
Christos K Kontos, Panagiotis G Adamopoulos, and Andreas Scorilas
Expert Review of Molecular Diagnostics, 2015, Volume 15, Number 12, Page 1567
[14]
Patrícia Isabel Marques, Filipa Fonseca, Tânia Sousa, Paulo Santos, Vânia Camilo, Zélia Ferreira, Victor Quesada, and Susana Seixas
Molecular Biology and Evolution, 2016, Volume 33, Number 1, Page 93
[15]
David L. Kolin, Keiyan Sy, Fabio Rotondo, Mena N. Bassily, Kalman Kovacs, Christine Brezden-Masley, Catherine J. Streutker, and George M. Yousef
Tumor Biology, 2016, Volume 37, Number 1, Page 437
[16]
Kleita Michaelidou, Alexandros Ardavanis, and Andreas Scorilas
Breast Cancer Research and Treatment, 2015, Volume 152, Number 2, Page 323
[17]
Panagiotis G. Adamopoulos, Christos K. Kontos, Sotirios G. Papageorgiou, Vassiliki Pappa, and Andreas Scorilas
Clinical Biochemistry, 2015, Volume 48, Number 13-14, Page 849
[18]
Christos K. Kontos, Dimitrios Chantzis, Iordanis N. Papadopoulos, and Andreas Scorilas
Cancer Letters, 2013, Volume 330, Number 1, Page 106
[19]
Andrea Grin, Sara Samaan, Monika Tripathi, Fabio Rotondo, Kalman Kovacs, Mena N. Bassily, and George M. Yousef
Human Pathology, 2015, Volume 46, Number 4, Page 541
[20]
Diane E. Peters, Benjamin Hoover, Loretta Grey Cloud, Shihui Liu, Alfredo A. Molinolo, Stephen H. Leppla, and Thomas H. Bugge
Toxicology and Applied Pharmacology, 2014, Volume 279, Number 2, Page 220
[21]
Andreas Scorilas and Konstantinos Mavridis
Expert Review of Molecular Diagnostics, 2014, Volume 14, Number 6, Page 713
[22]
Cristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Elisabet Cuyàs, BRUNA COROMINAS-FAJA, Esther Rodríguez-Gallego, Salvador Fernández-Arroyo, Begoña Martin-Castillo, Jorge Joven, and JAVIERABEL MENENDEZ MENENDEZ
Cell Cycle, 2014, Volume 13, Number 7, Page 1132
[23]
Spyridon Christodoulou, Dimitra K. Alexopoulou, Christos K. Kontos, Andreas Scorilas, and Iordanis N. Papadopoulos
Tumor Biology, 2014, Volume 35, Number 5, Page 4673
[24]
Ákos Végvári, Karin Sjödin, Melinda Rezeli, and György Marko-Varga
Journal of Proteome Research, 2013, Volume 12, Number 10, Page 4612
[25]
M. Schmitt, T. Renné, and A. Scorilas
Thrombosis and Haemostasis, 2013, Volume 110, Number 3, Page 396
[26]
J. Dorn, J. Bayani, G. M. Yousef, F. Yang, V. Magdolen, M. Kiechle, E. P. Diamandis, and M. Schmitt
Thrombosis and Haemostasis, 2013, Volume 110, Number 3, Page 408
[27]
Elena Kashuba, James Bailey, David Allsup, and Lynn Cawkwell
Biomarkers, 2013, Volume 18, Number 4, Page 279
[28]
Dimitra K. Alexopoulou, Iordanis N. Papadopoulos, and Andreas Scorilas
Clinical Biochemistry, 2013, Volume 46, Number 15, Page 1453
[29]
C. K. Kontos, K. Mavridis, M. Talieri, and A. Scorilas
Thrombosis and Haemostasis, 2013, Volume 110, Number 3, Page 450

Comments (0)

Please log in or register to comment.
Log in